Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.1091 | 46 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.13852 | 48 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.09874 | 47 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.07593 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.07202 | 48 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.1315 | 45 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.10578 | 44 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.10631 | 47 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.09454 | 47 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.10477 | 47 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.09177 | 47 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.09742 | 48 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.09959 | 46 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.09115 | 47 |